ENG rs1085307432: Understanding Hereditary Hemorrhagic Telangiectasia
The rs1085307432 variant is located within the ENG gene, which provides instructions for creating the endoglin protein. This variant is associated with hereditary hemorrhagic telangiectasia (HHT), a rare genetic condition that affects the development of blood vessels.
What each genotype means
Typical ENG genotype
This genotype represents the common, non-pathogenic state for this location in the ENG gene. It is not associated with the development of hereditary hemorrhagic telangiectasia (HHT) based on current clinical knowledge.
This is the most common genotype found in the general population across all ancestries.
Potential HHT-associated variant
This genotype indicates the presence of one copy of a variant in the ENG gene. Because HHT is an autosomal dominant condition, the presence of a pathogenic variant in one copy of the gene is sufficient to potentially cause the disorder, though clinical expression can be highly variable. Please consult with a genetic counselor or medical specialist to discuss the clinical significance of this specific variant in the context of your personal and family health history.
This genotype is rare, as pathogenic variants in the ENG gene are estimated to occur at a very low frequency in the general population.
Potential HHT-associated variant
This genotype indicates the presence of two copies of a variant in the ENG gene. While HHT is typically inherited in an autosomal dominant pattern, the presence of two copies may have implications for disease expression or severity that differ from a single-copy carrier. You should discuss these results with a healthcare provider or clinical geneticist to understand the specific implications for your health.
This genotype is extremely rare in the general population.
What is the rs1085307432 Variant?
The rs1085307432 variant is a specific change in the DNA sequence of the ENG gene. In genomics, an rsID (reference SNP cluster ID) acts as a unique identifier for a specific location in the human genome where a variation has been observed. This particular variant is categorized as a trait-associated marker. Because it is located within the ENG gene, researchers study it to understand how changes in this specific DNA sequence might influence the production or function of the endoglin protein. Genetic variants like this are identified through large-scale sequencing efforts and are cataloged to help scientists map the relationship between our genetic code and various health conditions. It is important to note that the presence of a variant does not automatically imply a specific health outcome, as many factors, including other genes and environmental influences, contribute to human health.
The Role of the ENG Gene
The ENG gene encodes a protein called endoglin, which is a major glycoprotein found on the surface of vascular endothelial cells—the cells that line the interior of blood vessels. Endoglin functions as a component of the transforming growth factor-beta (TGF-beta) receptor complex. This signaling pathway is critical for the proper development, maintenance, and stability of blood vessels throughout the body. When the ENG gene is altered, the resulting endoglin protein may not function correctly, which can disrupt the delicate balance of signals required for healthy vessel formation. This disruption is the underlying mechanism for hereditary hemorrhagic telangiectasia (HHT), a condition characterized by the development of abnormal blood vessels, such as telangiectasias (small, dilated vessels) and arteriovenous malformations (direct connections between arteries and veins).
Research and Evidence Strength
Current research associates variants in the ENG gene with HHT, specifically HHT type 1. The evidence strength for the association between pathogenic variants in this gene and the clinical presentation of HHT is considered moderate to strong in the scientific literature. Studies have shown that mutations in ENG and the related ACVRL1 gene account for the vast majority of classic HHT cases. While many variants in ENG have been identified and characterized, the specific clinical impact of any single variant, such as rs1085307432, depends on how it affects the protein's structure or expression. Because HHT is an autosomal dominant disorder, even a single copy of a pathogenic variant can be sufficient to manifest symptoms. Researchers continue to use clinical evaluations and molecular assays to determine the pathogenicity of specific variants, ensuring that genetic findings are interpreted within the context of a patient's overall health.
Population Frequency and Interpretation
The rs1085307432 variant is classified as rare in the general population. In genetics, a variant is considered rare if it appears in a very small percentage of individuals across diverse ancestral groups. Because this variant is rare, it is not typically found in the general population, and its presence is usually investigated in the context of clinical diagnostic testing for individuals who exhibit symptoms of vascular disorders. It is important to understand that genetic information is complex; the presence of a rare variant does not constitute a medical diagnosis. If you have received information about this variant through genetic testing, it is essential to discuss the results with a qualified healthcare provider or a genetic counselor. They can help interpret the findings in the context of your personal and family medical history and provide appropriate guidance regarding any necessary clinical follow-up.
How common is this variant?
The rs1085307432 variant is documented as rare across global populations, meaning it is not commonly observed in the general public.
Frequently asked questions
What is hereditary hemorrhagic telangiectasia?
Hereditary hemorrhagic telangiectasia (HHT) is a rare genetic disorder that causes abnormal blood vessel development. It can lead to frequent nosebleeds, skin spots, and more serious internal vascular malformations.
Does having this variant mean I have HHT?
No, having a genetic variant does not automatically mean you have a condition. Genetic testing results should always be interpreted by a medical professional who can correlate them with your physical symptoms and family history.
How is HHT diagnosed?
Diagnosis is typically based on clinical criteria, such as the Curaçao criteria, which include symptoms like recurrent nosebleeds and telangiectasias. Genetic testing for variants in genes like ENG can support a clinical diagnosis.
What should I do if I have this variant?
If you are concerned about a genetic finding, you should consult with a genetic counselor or a physician. They can provide context, explain the implications, and recommend any necessary screening or monitoring.
Sources & further reading
Educational information only, last refreshed 9/30/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1085307432?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in ENG
Genetic variant identified in the ENG gene, relevant for clinical screening of vascular disorders.
A known pathogenic mutation in the ENG gene linked to vascular malformations.
Pathogenic variant in the ENG gene associated with hereditary hemorrhagic telangiectasia type 1.
A variant in the ENG gene potentially impacting protein function related to vascular development.
This variant is located within the ENG gene, which is associated with hereditary hemorrhagic telangiectasia.
Clinically significant variant in the ENG gene associated with hereditary hemorrhagic telangiectasia.